Related Experiment Video
Updated: Oct 5, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic Significance of Controlling Nutritional Status Score (CONUT) in Patients Undergoing Pericardiocentesis
Emre Aruğaslan1, Ahmet Zengin2, Mehmet Baran Karataş2
1Department of Cardiology, Ankara City Hospital, Ankara.
Background:
Malnutrition is associated with a poor prognosis in cardiovascular diseases, however the prognostic impact of the Controlling Nutritional Status (CONUT) score in patients with pericardial effusion (PE) is not known.
Methods:
This was a retrospective study conducted among 301 consecutive patients with PE who underwent pericardiocentesis. CONUT score was calculated from serum albumin level, total cholesterol level and lymphocyte count. The prognostic role of admission CONUT score on long-term mortality was evaluated.
Results:
The patients were divided into two groups according to long-term mortality. A total of 131 patients died during follow-up. In multivariable regression analysis, chronic heart failure [hazard ratio (HR): 3.21, 95% confidence interval (CI): 1.18-8.70, p < 0.01], malignancy (HR: 5.67, 95% CI: 3.34-9.63, p < 0.01) and CONUT score (HR: 1.21, 95% CI: 1.10-1.33, p < 0.01) were found to be independent predictors of long-term mortality. CONUT score was significantly higher in the patients who died (5.8 ± 2.4 vs. 3.6 ± 2.2, p < 0.01). In receiver operating characteristics analysis, a CONUT score ≥ 4.5 predicted long-term mortality with 66% sensitivity and 69% specificity (area under curve: 0.73, 95% CI: 0.67-0.79, p < 0.01).
Conclusions:
In patients with PE, CONUT score is an independent prognostic factor for mortality.
More Related Videos
Related Concept Videos
Pericarditis IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy VI: Nursing Management
Mitral Regurgitation IV: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pericarditis III: Medical Management

